Active Substance: Tizanidine (as HCl).
Overview
Welcome to Dwaey, specifically on SIRDALUD 4mg page.
This medicine contains an important and useful components, as it consists of
Tizanidine (as HCl)is available in the market in concentration
Tizanidine
Hepatic or renal insufficiency. Children, elderly, pregnancy and lactation. Monitor LFT regularly. Stop treatment if liver enzymes are raised persistently >3 times upper limit of normal range. Avoid abrupt withdrawal of therapy. Lactation: May be excreted in breast milk due to lipophilic nature; use caution
Spasticity, Painful muscle spasm
Severe hepatic dysfunction.
>10% Dry mouth (46-50%),Somnolence (46-50%),Dizziness (16-20%),Asthenia (10-45%) 1-10% Blurred vision (3%),Constipation (4%),Infection (6%),LFT abnormalities (3-5%),Speech disorder (3%),Vomiting (3%),Urinary frequency (3%),UTI (10%) Frequency Not Defined Asthenia,Bradycardia,Hypotension,Orthostatic hypotension,Syncope (rare) Potentially Fatal: Hepatitis.
3
Tizanidine, an alpha2-adrenergic agonist, is a centrally acting muscle relaxant structurally related to clonidine. It reduces spasticity by increasing presynaptic inhibition of motor neurons and has no direct effect on skeletal muscle, the neuromuscular junction or on monosynaptic spinal reflexes.
Potentiates hypotensive effect of antihypertensives. Increased CNS effects with alcohol and CNS depressants. Increased bradycardia with ?-blockers and digoxin. Increased serum concentration of tizanidine with CYP1A2 inhibitors e.g. zileuton, ciprofloxacin and other fluoroquinolones, antiarrhythmics, cimetidine, famotidine, oral contraceptives, aciclovir and ticlopidine. Decreased serum concentrations of tizanidine with rifampicin. Use with caution with drugs that may prolong QT interval.
Information not available